Scholars Central

EditorialPublished 20 Aug 2020

Novel Anticancer Operators Show Guarantee to Control Tumor Development in Almost Every Disease Type

Authors: Sowmya Uttam

Medicinal Chemistry

Volume 10 · Issue 8 · Pages 1

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

A quality called MYC has gotten probably the most sweltering objective for disease specialists around the globe. MYC is known to drive tumor development in almost all disease types - however effectively focusing on the quality has demonstrated to be a test. One that has been astounding specialists for over three decades. Presently, scientists at Purdue University have found a novel arrangement of MYC advertiser G-quadruplex stabilizers that have shown anticancer action in human malignant growth cell societies. The revelation is distributed in the July 8 version of the Journal of the American Chemical Society.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Medicinal Chemistry.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalMedicinal Chemistry
  • SubjectChemistry
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Sowmya Uttam”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels